Biocon Biologics Refinances USD 1.1 Billion Long Term Debt through USD Bonds and New Syndicated Facility
Biocon Biologics Limited ("BBL" and "Company"), a subsidiary of Biocon Limited (BSE code: 532523, NSE: BIOCON), today announced the successful pricing of Biocon Biologics' debut USD 800 million (INR 66,763 million) senior secured …